Meet Sébastien - Medical Director Oncology
Bristol-Myers Squibb Canada
As a medical director and past researcher, Sébastien is committed to making a difference in the lives of patients; striving to do right by patients by bringing transformational medications to market quicker and helping identify more relevant and optimal treatments. “I can retire with satisfaction the day somebody feels better as a result of something we accomplished.”
Bristol-Myers Squibb’s patients-first core values keep Sébastien motivated. He believes that his company’s ongoing work in oncology will significantly improve patient outcomes, allowing cancer patients to hope for the potential of long-term survival. “At the end of the day, we want to do right by patients. We have a real responsibility to help evolve medicine, especially when current options fail. We also strive to help close the gap between a patient’s reality and the realities of the healthcare system.”
“At the end of the day, we want to do right by patients.”
In Sébastien’s role as Medical Director in Oncology, the patient stories that often make their way back to him provide a true sense of purpose. On Christmas Eve in 2013, at the explicit request of a family with a loved one afflicted with cancer and benefiting from a BMS medication, Sébastien received an email from a Canadian physician relaying the family’s thanks towards all BMS members for allowing them to enjoy an additional joyful holiday period together. Sébastien keeps the email on his desk and refers to it often as a constant reminder of the reality of patients, family and caregivers that are all ultimately relying on the discovery and availability of new treatment options. Through his work, he proactively seeks to drive forward the evolution needed to help families maintain quality of life when faced with the adversity of serious diseases. “We have to have the courage of our convictions.”
Who is Sébastien working for? He is working for all current patients needing tangible hope for their future, for all past patients for which treatment options were unfortunately not good enough, and for the promise of a world where a cancer diagnosis does not necessarily equal a death sentence.